Skip to content
healthcare.dev
Get a free key

OSELTAMIVIR PHOSPHATE

NDC 69097-904, OSELTAMIVIR PHOSPHATE, for suspension, from Cipla USA, Inc.

Product NDC
69097-904
Status
Listed
Labeler
Cipla USA, Inc
Dosage form
FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212858
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-904 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OSELTAMIVIR PHOSPHATE6 mg/mL

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
69097-904-43690970904431 BOTTLE in 1 CARTON (69097-904-43) / 60 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7d04f367-8f62-4f63-bac9-717d14f555a5

Use it

Look up 69097-904 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-904 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-904. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.